Combined use of cyclophosphamide and Chalone 19-peptide in experimental breast cancer

BACKGROUND: Cyclophosphamide is a potent anticancer drug, but its clinical utility is limited because of its severe side effects, in particular liver damage. Chalone 19-peptide induces apoptosis of tumor cells and inhibits tumor growth. The present study investigated the antitumor effects of a combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yuanxi, He, Yan, Ye, Shengqian, Li, Xiaomei, Zhong, Qingqi, Chen, Zhuo, Jin, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712081/
https://www.ncbi.nlm.nih.gov/pubmed/23874108
http://dx.doi.org/10.2147/OTT.S44564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712081/
https://www.ncbi.nlm.nih.gov/pubmed/23874108
http://dx.doi.org/10.2147/OTT.S44564

Ejemplares similares